Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
2.099
-0.086 (-3.93%)
Jan 22, 2025, 12:10 PM EST - Market open
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $14.68 million as of January 22, 2025. Its market cap has decreased by -67.67% in one year.
Market Cap
14.68M
Enterprise Value
48.76M
1-Year Change
-67.67%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $14.68M, a decrease of -86.73%. That is a compound annual growth rate of -17.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 15.30M | -1.29% |
| Dec 31, 2024 | 15.50M | -63.95% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 656.33B |
| UnitedHealth Group | 480.14B |
| Johnson & Johnson | 356.45B |
| Novo Nordisk | 341.33B |
| AbbVie | 303.85B |
| Merck & Co. | 244.06B |
| Thermo Fisher Scientific | 217.87B |
| Intuitive Surgical | 212.13B |